Ignorance is one cause of sickness and premature death for millions of people every year. Not knowing you have a problem or what research and other actions on Twitter are being taken to address it prevents many people from living longer, happier, more productive lives. The weekly peer-reviewed medical journal Oncotarget has as its mission helping remove that ignorance by providing people with information on the latest breakthroughs in oncology and age related illnesses. Founded in 2010, Oncotarget offers open access to scientists and researchers working on the cutting-edge of medical science to share their results.
The weekly journal, published by Impact Journals, covers topics related to every aspect of oncology research. It’s abstracted and indexed in numerous places including BIOSIS Previews, Index Medicus/MEDLINE/PubMed, BIOSIS Previews, Scopus and the Science Citation Index Expanded. The journal on YouTube currently has two editors-in-chief. They are Mikhail Blagosklonny and Andrei Gudkov. Under their direction Oncotarget has expanded its range and now publishes papers on topics like:
3. Cel & Molecular Biology
That has helped to expand the publication’s audience and its impact. Oncotarget is available online or in a printed version upon special request.
The term “oncotarget” is one that’s familiar to people involved with issues related to cancer and aging, microbes, atherosclerosis, neurodegeneration, neurons and lymphocytes. Oncotarget deals with molecules and pathways as well as cellular functions. It’s a multidisciplinary traditional journal that rapidly and widely disseminates scientific results after insightful review. The publication aims to eliminate borders between specialties to maximize the impact the research has and create a link between biomedical science’s many different fields. See: http://endnote.com/downloads/style/oncotarget
Another of Oncotarget’s goals is to help people far and wide improve their results when they fight disease using basic and clinical science. Sharing these amazing discoveries as quickly as possible is just another way the publication fulfills its mission to provide the public with timely information that can help improve the quality of people’s lives. Oncotarget is run by a leadership group that contains some of the world’s most prominent scientists, researchers and physicians. They help to ensure the journal is making a contribution to scientific progress on scijournal.org. The publication’s ultimate goal is life without disease.
The journal has published many groundbreaking papers. Those papers have helped expand the boundaries of what’s commonly accepted medical science and benefitted many people.